Skip to main content
Clinical Trials/NL-OMON54213
NL-OMON54213
Recruiting
Not Applicable

Endoscopic ultrasonography-guided gastroenterostomy versus surgical gastrojejunostomy for palliation of malignant gastric outlet obstruction (ENDURO-study) - ENDURO-study

niversitair Medisch Centrum Utrecht0 sites96 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Malignant gastric outlet obstruction
Sponsor
niversitair Medisch Centrum Utrecht
Enrollment
96
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
niversitair Medisch Centrum Utrecht

Eligibility Criteria

Inclusion Criteria

  • \- Adult patients with symptomatic malignant gastric outlet obstruction,
  • presenting with nausea, vomiting and/or inability to eat
  • \- Gastric Outlet Obstruction Scoring System Score of 0 (no oral intake) or 1
  • (liquids only)
  • \- Obstruction due to irresectable or metastatic malignancy without curative
  • treatment options
  • \- Radiologically or endoscopically confirmed gastric outlet obstruction
  • \- Location of obstruction extending from the distal 1/3 of the stomach (antrum)
  • to the distal duodenum (third part)
  • \- Both treatments (SGJ and EUS\-GE) are technically and clinically feasible

Exclusion Criteria

  • \- Radiological or clinical suspicion of other strictures or obstructions along
  • the gastrointestinal tract (distal of Treitz), with small intestine intestinal
  • dilation/ileus. Note: patients with diffuse dilatation of the intestines should
  • not be excluded;
  • \- Cancer extending into the body of the stomach or around the ligament of
  • \- Duodenal tube feeding is not tolerated by the patient, despite adequate
  • position of the tube;
  • \- Altered anatomy after previous gastric, periampullary or duodenal surgery;
  • \- Previous SGJ as palliative treatment for the same condition;
  • \- Inability to undergo surgery or upper endoscopy due to severe comorbidities;

Outcomes

Primary Outcomes

Not specified

Similar Trials